LyfeSci Research & Innovation, a full-service clinical research organization (CRO), announces the acquisition of Clinically Media, a patient recruitment company specializing in data-driven, inclusive enrollment strategies. The acquisition integrates patient recruitment directly into LyfeSci’s CRO model, expanding its end-to-end clinical trial capabilities. Clinically Media’s expertise across dermatology, neurology, and psychiatry supports LyfeSci’s current areas of focus while strengthening its ability to expand into additional therapeutic areas.
Read the full article: LyfeSci Research & Innovation Acquires Clinically Media to Expand Patient-Centric Clinical Trial Capabilities //
Source: https://www.businesswire.com/news/home/20260109474518/en/LyfeSci-Research-Innovation-Acquires-Clinically-Media-to-Expand-Patient-Centric-Clinical-Trial-Capabilities